Singh Rakesh K, Lange Thilo S, Kim Kyukwang, Zou Yongping, Lieb Casey, Sholler Giselle L, Brard Laurent
Molecular Therapeutics Laboratory, Program in Women's Oncology, Department of Obstetrics and Gynecology, Women and Infants' Hospital, The Warren Alpert Medical School of Brown University, 101 Dudley Street, Providence, RI 02905, USA.
Bioorg Med Chem Lett. 2007 Nov 1;17(21):5846-52. doi: 10.1016/j.bmcl.2007.08.032. Epub 2007 Aug 19.
Several indole ethyl isothiocyanate (IEITC) analogs were designed, synthesized, and screened to evaluate their cytotoxicity against neuroblastoma (NB) cells in-vitro. In NB, predominantly a tumor of early childhood, survival remains low despite aggressive treatments. Therefore, novel treatment strategies are greatly needed. The objective of the present study was to study the therapeutic potential of IEITC by analyzing the cytotoxic, anti-proliferative, and apoptotic effects on NB cell lines. 7-Methyl-indole-3-ethyl isothiocyanate (7Me-IEITC) proved to be cytotoxic to various NB cell lines (SMS-KCNR, SK-N-SH, SH-SY5Y, and IMR-32) with an IC(50) at 2.5-5.0 microM, while primary control cells (lung fibroblasts) were not affected. 7Me-IEITC led to the activation of apoptotic markers caspase-3, -8, and -9, caused activation of pro-apoptotic p38 MAPK and SAP/JNK, and down-regulated pro-survival factor AKT in SMS-KCNR cells. Moreover, 7Me-IEITC displayed anti-proliferative effects (IC(50) at 600 nM) and caused an arrest in cell cycle progression. This wide effect of 7Me-IEITC on NB cell signaling and survival suggests that it could be developed as a therapeutic agent against neuroblastoma.
设计、合成并筛选了几种吲哚乙基异硫氰酸酯(IEITC)类似物,以评估它们在体外对神经母细胞瘤(NB)细胞的细胞毒性。在NB中,这主要是一种儿童早期肿瘤,尽管进行了积极治疗,生存率仍然很低。因此,迫切需要新的治疗策略。本研究的目的是通过分析对NB细胞系的细胞毒性、抗增殖和凋亡作用,研究IEITC的治疗潜力。7-甲基吲哚-3-乙基异硫氰酸酯(7Me-IEITC)被证明对各种NB细胞系(SMS-KCNR、SK-N-SH、SH-SY5Y和IMR-32)具有细胞毒性,IC50为2.5-5.0微摩尔,而原代对照细胞(肺成纤维细胞)未受影响。7Me-IEITC导致凋亡标志物caspase-3、-8和-9的激活,引起促凋亡p38 MAPK和SAP/JNK的激活,并下调SMS-KCNR细胞中的促存活因子AKT。此外,7Me-IEITC显示出抗增殖作用(IC50为600纳摩尔),并导致细胞周期进程停滞。7Me-IEITC对NB细胞信号传导和存活的这种广泛作用表明,它可以被开发成为一种抗神经母细胞瘤的治疗药物。